Accendra Health, Inc.

ACH · NYSE · Stock · Healthcare
$0.28
-10.60% today
Delayed price,

What Accendra Health does

Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services. The company also supplies other home medical equipment, patient care product lines including ostomy, wound care and negative pressure wound therapy, urology, incontinence, and other products and services. It serves patients and home health agencies. The company was formerly known as Owens & Minor, Inc. and changed its name to Accendra Health, Inc. in December 2025. Accendra Health, Inc. was founded in 1882 and is based in Glen Allen, Virginia.

Key facts

Sector
Healthcare
Industry
Medical Distribution
Market cap
$21.7M
P/E (ttm)
—
Forward P/E
3.3
Dividend yield
0.00%
Beta
1.57
Profit margin
-11.4%
Employees
6,500
Headquarters
Glen Allen, VA, United States
Exchange
NYSE

Performance

1 Month
-68.3%
3 Months
-91.9%
6 Months
-91.6%
1 Year
-94.1%
5 Years
-99.3%
$0.2852-week range$5.60
Biggest setback — last 12 months
-94.9%
20 Oct 2025 → 14 Oct 2026
Fell from $5.51 to $0.28 — its sharpest sustained decline this year.
Biggest run-up — last 12 months
+90.8%
16 Mar 2026 → 27 Apr 2026
Ran from $1.96 to $3.74 — its strongest sustained advance this year.

Price outlook — trend & volatility model

▼ Trend: Downtrend
Price is below its 20-, 50- and 200-day averages, each stacked below the next — a classic technical downtrend structure.
HorizonBear case (−1σ)Base caseBull case (+1σ)
1 Month$0.19 (-32.5%)$0.28$0.42 (+48.2%)
3 Months$0.14 (-49.4%)$0.28$0.56 (+97.7%)
6 Months$0.11 (-61.9%)$0.28$0.74 (+162.2%)
12 Months$0.07 (-74.4%)$0.28$1.10 (+290.8%)
Statistical, not machine-learning: a random-walk (no assumed drift) volatility model built from this ticker's own realized price history, plus a purely descriptive moving-average trend read. Illustrative only — not a price target and not financial advice. The bear and bull cases sit one standard deviation (1σ) below and above today's price, a range that covers about 68% of the outcomes the model treats as plausible, not a 68% chance of either case. Annualized volatility used: 136.3%, blended from this ticker's own 3-month and 1-year realized price history. Base case is deliberately flat — this quantifies a possible range, not a directional prediction. See the full model, including wider (≈95%) bands →

Comparable companies

Recent insider activity

Acquired 283,554 shares — Gardner-Smith Kenneth, President & CEO · 2026-10-06
Sold 4,265 shares at $0.85 — Leon Jonathan A, EVP & CFO · 2026-09-24
Sold 1,822 shares at $2.91 — Galloway Heath H, EVP,General Counsel & CorpSecy · 2026-05-20
Sold 1,770 shares at $3.04 — Leon Jonathan A, EVP & CFO · 2026-05-19
Sold 17,692 shares at $3.04 — Pesicka Edward A, President & CEO · 2026-05-19
Source: SEC Form 4 filings. An "acquired" entry with no price is typically a stock award or option exercise rather than an open-market purchase. Search all insider trades →

Learn the basics

Prices and company data are delayed reference figures from public sources (Yahoo Finance, SEC EDGAR) and may be inaccurate or out of date. This page is informational only — it is not investment advice or a recommendation to buy or sell any security. Past performance does not indicate future results.